{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:15Z","timestamp":1792791555116,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111178","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:10:00Z","timestamp":1788448200000},"page":"111178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Purinergic signaling: A tribute to Francesco Di Virgilio"],"prefix":"10.1016","volume":"301","author":[{"given":"Peter","family":"Illes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pelegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Adinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111178_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110976","article-title":"P2X receptors in immune cells: key regulators of inflammation and immune function","volume":"294","author":"Adinolfi","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib2","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases in vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2026.111178_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110948","article-title":"P2X7 receptor or TNAP genetic blockade prevents the reduction of neuronal CTCF detected in tauopathy","volume":"292","author":"Aivar","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110784","article-title":"P2X purinergic receptors are required for correct cortical development in human brain organoids","volume":"284","author":"Benito-Le\u00f3n","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110724","article-title":"Adenosine A(2A) receptor blockade promotes oligodendrocyte differentiation and myelination: highlighting the potency of an edaravone-conjugated A(2A) receptor antagonist","volume":"282","author":"Cherchi","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib6","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","article-title":"Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine","volume":"9","author":"Chiozzi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111178_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110783","article-title":"Purinergic signaling in stroke and multiple sclerosis: prospects for therapies","volume":"284","author":"Cisneros-Mejorado","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","article-title":"Liaisons dangereuses: P2X(7) and the inflammasome","volume":"28","author":"Di Virgilio","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111178_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2026.111178_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuropharm.2026.111178_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109333","article-title":"Extracellular ATP: a powerful inflammatory mediator in the central nervous system","volume":"224","author":"Di Virgilio","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110973","article-title":"Targeting the purinergic P2X7 receptor in epilepsy: cell types matter","volume":"294","author":"Engel","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11302-026-10135-9","article-title":"In tribute to Francesco Di Virgilio, a great scientist and a wonderful friend","volume":"22","author":"Falzoni","year":"2026","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2026.111178_bib14","article-title":"The P2X7 receptor is a master regulator of microparticle and mitochondria exchange in mouse microglia","volume":"5","author":"Falzoni","year":"2024","journal-title":"Function (Oxford, England)"},{"key":"10.1016\/j.neuropharm.2026.111178_bib15","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111178_bib16","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1016\/S0021-9258(19)81521-1","article-title":"Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms","volume":"263","author":"Greenberg","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111178_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110645","article-title":"Enteric glia and purinergic signaling in health and disease","volume":"279","author":"Gulbransen","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.111048","article-title":"Purinergic signaling and cancer neuroscience","volume":"298","author":"Hu","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib19","volume":"vol. 80","author":"Illes","year":"2025"},{"key":"10.1016\/j.neuropharm.2026.111178_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110955","article-title":"Targeting purinergic receptors in glioblastoma with nanobody-displaying AAV vectors","volume":"293","author":"Jargalsaikhan","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110876","article-title":"The neuronal P2X7R controversy: revisiting evidence, methods, and unresolved questions","volume":"289","author":"Kachappilly","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110497","article-title":"P2 purinergic signaling and pruritus","volume":"275","author":"Liu","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.111051","article-title":"Study on the effect and mechanism of sesamin on P2X3-related cheek allergic contact dermatitis in mice induced by SADBE stimulation","volume":"297","author":"Ma","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110877","article-title":"P2X7 receptors as targets for neuroprotection","volume":"289","author":"Maneu","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib25","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1091\/mbc.e05-03-0222","article-title":"A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion","volume":"16","author":"Pellegatti","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuropharm.2026.111178_bib26","doi-asserted-by":"crossref","first-page":"C1538","DOI":"10.1152\/ajpcell.1998.275.6.C1538","article-title":"Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations","volume":"275","author":"Perregaux","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111178_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.111049","article-title":"Targeting P2X receptor signaling for chronic visceral pain and beyond","volume":"298","author":"Shen","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.111087","article-title":"Purinergic-cytokine signaling as a regulatory axis in neuroimmune development","volume":"299","author":"Silva","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1990.tb37666.x","article-title":"Effects of extracellular ATP on mononuclear phagocytes","volume":"603","author":"Steinberg","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111178_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neuropharm.2026.111178_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110566","article-title":"Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection","volume":"278","author":"Szab\u00f3","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2026.110949","article-title":"A bioluminescent ratiometric sensor for the measurement of extracellular ATP concentration in inflammation and cancer","volume":"292","author":"Tarantini","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.7150\/thno.66274","article-title":"Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation","volume":"12","author":"Vultaggio-Poma","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2026.111178_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110723","article-title":"UDPG\/P2Y(14)-STAT1 axis mediates LPS-induced reactive astrogliosis","volume":"283","author":"Wang","year":"2026","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111178_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110705","article-title":"Astrocytic Connexin43 in Alzheimer's disease: mechanisms, interaction with P2 receptors, and therapeutic potential","volume":"282","author":"Xiong","year":"2026","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:55:31Z","timestamp":1792788931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"alternative-id":["S0028390826003539"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111178","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic signaling: A tribute to Francesco Di Virgilio","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111178"}}